Tag - Kim Woo-bin

28Jun

‘Please don’t damage our beautiful memories’: Kim Woo-bin flooded with mixed reactions from BTS fans after buying group’s former building

It’s probably just another building to others but for some fans it meant more. South Korean actor Kim Woo-bin recently bought the building that housed the former headquarters of Hybe (formerly known as Big Hit Entertainment), the company that manages popular K-pop boy band BTS. The 34-year-old reportedly acquired it for 13.7 billion won (S$13.4 million). According to...

By Entertainment, Korea, , 0 CommentsRead more...
04Apr

Kim Woo Bin’s Dystopian Series “Black Knight” Will Air in May

After being diagnosed with nasopharyngeal cancer in 2017, Korean actor Kim Woo Bin took a two-year hiatus to focus on his treatment and health. Resuming work, he had starred in the sci-fi film Alienoid and can be seen next in Black Knight. The original Netflix series will be released on May 12, 2023, Based on the popular webtoon, Delivery Knight, the dystopian...

By Entertainment, Movie, , , , 0 CommentsRead more...
20Sep

Kim Woo Bin and Shin Min Ah Spotted Vacationing in Paris

Putting his flourishing career on hold in 2017 after being diagnosed with nasopharyngeal cancer, Korean actor Kim Woo Bin underwent two years of treatment before making a full recovery. Making his comeback in 2020, he starred in drama Our Blues, as well as the upcoming Netflix series, Black Knight. During his health setback, Kim Woo Bin was fully supported by his girlfriend Shin...

By Entertainment, Korea, , , 0 CommentsRead more...
12Aug

9 dramas and films starring Kim Woo-bin we recommend everyone to watch

From his piercing eyes and bushy brows to his chiselled cheekbones and jawline, Kim Woo-bin has caught our eyes since his breakout role in the popular 2013 Korean drama The Heirs. The South Korean model-turned-actor was enjoying a tremendous uptick in popularity that was unfortunately halted due to a diagnosis of nasopharyngeal cancer in 2017. Kim Woo-bin,...

By Entertainment, Korea, , 0 CommentsRead more...